USE OF A COMBINATION OF AN ATYPICAL ANTIPSYCHOTIC AND A SEROTONIN REUPTAKE INHIBITOR FOR TREATMENT OF PSYCHOSIS

The invention provides pharmaceutical compositions which comprise a first component which is an atypical anti-psychotic in combination with a second component which is a serotonin reuptake inhibitor, use of such compositions for treating a patient suffering from or susceptible to psychosis, acute ma...

Full description

Saved in:
Bibliographic Details
Main Authors TOLLEFSON, GARY DENNIS, PERRY, KENNETH WAYNE, BYMASTER, FRANKLIN PORTER
Format Patent
LanguageEnglish
French
Published 18.11.2008
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The invention provides pharmaceutical compositions which comprise a first component which is an atypical anti-psychotic in combination with a second component which is a serotonin reuptake inhibitor, use of such compositions for treating a patient suffering from or susceptible to psychosis, acute mania, mild anxiety states, or depression in combination with psychotic episodes, and particularly such compositions which comprise a first component which is olanzapine and a second component which is fluoxetine hydrochloride.
Bibliography:Application Number: CA19972264941